[The chemotherapy of urologic neoplasms]
- PMID: 359509
[The chemotherapy of urologic neoplasms]
Abstract
The newest aspects for the use of cytostatic agents in the treatment of bladder, prostatic and testicular carcinomas are presented. Especially the two new drugs diaminodichlor cisplatinum and adriamycin are discussed as to their potential use in these diseases.
Similar articles
-
[A new cytostatic agent: cis-dischlorodiamin platinum II (DDP)].MMW Munch Med Wochenschr. 1979 May 4;121(18):624-7. MMW Munch Med Wochenschr. 1979. PMID: 108586 German. No abstract available.
-
Chemotherapy of urologic malignancies.Semin Urol. 1985 Nov;3(4):239-80. Semin Urol. 1985. PMID: 3916569 Review. No abstract available.
-
[Phase II study on cis-diamminedichloroplatinum (II) by a collaborative study].Gan To Kagaku Ryoho. 1982 Jan;9(1):46-54. Gan To Kagaku Ryoho. 1982. PMID: 6892191 Japanese.
-
[Chemotherapy and radiotherapy for urological cancer].Gan To Kagaku Ryoho. 2002 May;29(5):709-16. Gan To Kagaku Ryoho. 2002. PMID: 12040674 Review. Japanese.
-
Phase II trial adriamycin and cis-dichlorodiammineplatinum(II) in squamous cell, ovarian, and testicular carcinomas.Cancer Treat Rep. 1978 Aug;62(8):1211-3. Cancer Treat Rep. 1978. PMID: 356979 Clinical Trial. No abstract available.